Bayer under investigation in China over drug prices
Bayer has become the latest pharma company to come under investigation in China in a probe of drug firms over high prices.
The company announced today that it had been visited by Chinese authorities in late August to investigate a potential case of unfair competition.
In an email statement to Reuters, Bayer said, “we are taking the investigation seriously and are fully cooperating with the authority“.
Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.